SELLAS Life Sciences Group Inc (SLS)
1.33
-0.02
(-1.48%)
USD |
NASDAQ |
May 03, 16:00
1.315
-0.02
(-1.13%)
After-Hours: 20:00
SELLAS Life Sciences Group Revenue (Quarterly)
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | 1.00M |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | 1.90M |
| March 31, 2021 | 5.70M |
| December 31, 2020 | 1.90M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 2.331M |
| March 31, 2014 | 2.173M |
| December 31, 2013 | -1.17M |
| September 30, 2013 | 1.17M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.00M
Minimum
Mar 2022
5.70M
Maximum
Mar 2021
2.625M
Average
1.90M
Median
Dec 2020
Revenue (Quarterly) Benchmarks
| Geron Corp | 0.304M |
| Immuneering Corp | -- |
| Protagonist Therapeutics Inc | 60.00M |
| Akebia Therapeutics Inc | 56.20M |
| Moderna Inc | 167.00M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.136M |
| Total Expenses (Quarterly) | 8.177M |
| EPS Diluted (Quarterly) | -0.25 |
| Enterprise Value | 72.31M |
| Earnings Yield | -102.3% |
| Normalized Earnings Yield | -161.21 |